|
BO42207 |
PROTAC BRD4 Degrader-19 |
2684292-71-3 |
C44H38N8O5S2 |
822.9531 |
VIEW DETAILS > |
|
BO43606 |
Vicatertide |
1251838-01-3 |
C42H66N10O10 |
871.0344 |
VIEW DETAILS > |
|
BO48376 |
MI-432 |
1268874-09-4 |
C33H35Cl2F6N5O7S |
830.6217 |
VIEW DETAILS > |
|
BO51638 |
BMS-986365 |
2446928-30-7 |
C41H45F3N8O5S |
818.9068 |
VIEW DETAILS > |
|
BO52964 |
tert-Butyl ((63S,4S,Z)-11-ethyl-12-(2-((S)-1-methoxyethyl)-5-(piperazin-1-yl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)carbamate |
2865127-16-6 |
C43H58N8O6S |
815.0356 |
VIEW DETAILS > |
|
BR89907 |
Benzyl (S)-4-[5-[5-bromo-3-[3-[(tert-butyldiphenylsilyl)oxy]-2,2-dimethylpropyl]-1H-indol-2-yl]-6-(1-methoxyethyl)pyridin-3-yl]piperazine-1-carboxylate |
2641451-80-9 |
C49H57BrN4O4Si |
873.9908 |
VIEW DETAILS > |
|
AG94418 |
FORMIC-D ACID, POTASSIUM SALT |
57444-81-2 |
CHKO2 |
84.1157 |
VIEW DETAILS > |
|
AG53592 |
[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[3-[2-(2-hexanoylsulfanylethylcarbamoyl)ethylcarbamoyl]-3-hydroxy-2,2-dimethyl-propoxy]-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
5060-32-2 |
C27H46N7O17P3S |
865.6771 |
VIEW DETAILS > |
|
BM31504 |
(Dimethylphenylphosphine)(1,5-cyclooctadiene)[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]iridium(I) hexafluorophosphate |
1019853-04-3 |
C37H48F6IrN2P2 |
888.9454 |
VIEW DETAILS > |
|
BA56912 |
(R)-2-(1-NAPHTHYL)-8-DIPHENYLPHOSPHINO-1-[(S)-3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA-[2,1-A,3,4-A']-DINAPHTHALEN-4-YL]-1,2-DIHYDROQUINOLINE TOLUENE ADDUCT |
1204139-01-4 |
C58H85NO2P2 |
890.2485 |
VIEW DETAILS > |